These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1058 related articles for article (PubMed ID: 28978689)
1. NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data. Jurtz V; Paul S; Andreatta M; Marcatili P; Peters B; Nielsen M J Immunol; 2017 Nov; 199(9):3360-3368. PubMed ID: 28978689 [TBL] [Abstract][Full Text] [Related]
2. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes. Zhao W; Sher X PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041 [TBL] [Abstract][Full Text] [Related]
3. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Nielsen M; Andreatta M Genome Med; 2016 Mar; 8(1):33. PubMed ID: 27029192 [TBL] [Abstract][Full Text] [Related]
4. Improved Prediction of Bovine Leucocyte Antigens (BoLA) Presented Ligands by Use of Mass-Spectrometry-Determined Ligand and in Vitro Binding Data. Nielsen M; Connelley T; Ternette N J Proteome Res; 2018 Jan; 17(1):559-567. PubMed ID: 29115832 [TBL] [Abstract][Full Text] [Related]
5. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01. Pedersen LE; Rasmussen M; Harndahl M; Nielsen M; Buus S; Jungersen G Immunogenetics; 2016 Feb; 68(2):157-65. PubMed ID: 26572135 [TBL] [Abstract][Full Text] [Related]
6. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands. Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B Front Immunol; 2018; 9():1795. PubMed ID: 30127785 [TBL] [Abstract][Full Text] [Related]
7. NetMHCpan, a method for MHC class I binding prediction beyond humans. Hoof I; Peters B; Sidney J; Pedersen LE; Sette A; Lund O; Buus S; Nielsen M Immunogenetics; 2009 Jan; 61(1):1-13. PubMed ID: 19002680 [TBL] [Abstract][Full Text] [Related]
8. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods. Zhang H; Lundegaard C; Nielsen M Bioinformatics; 2009 Jan; 25(1):83-9. PubMed ID: 18996943 [TBL] [Abstract][Full Text] [Related]
9. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data. Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519 [TBL] [Abstract][Full Text] [Related]
10. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Reynisson B; Alvarez B; Paul S; Peters B; Nielsen M Nucleic Acids Res; 2020 Jul; 48(W1):W449-W454. PubMed ID: 32406916 [TBL] [Abstract][Full Text] [Related]
11. Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity. Rasmussen M; Fenoy E; Harndahl M; Kristensen AB; Nielsen IK; Nielsen M; Buus S J Immunol; 2016 Aug; 197(4):1517-24. PubMed ID: 27402703 [TBL] [Abstract][Full Text] [Related]
12. Improved pan-specific MHC class I peptide-binding predictions using a novel representation of the MHC-binding cleft environment. Carrasco Pro S; Zimic M; Nielsen M Tissue Antigens; 2014 Feb; 83(2):94-100. PubMed ID: 24447175 [TBL] [Abstract][Full Text] [Related]
13. Footprints of antigen processing boost MHC class II natural ligand predictions. Barra C; Alvarez B; Paul S; Sette A; Peters B; Andreatta M; Buus S; Nielsen M Genome Med; 2018 Nov; 10(1):84. PubMed ID: 30446001 [TBL] [Abstract][Full Text] [Related]
14. Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system. Paul S; Croft NP; Purcell AW; Tscharke DC; Sette A; Nielsen M; Peters B PLoS Comput Biol; 2020 May; 16(5):e1007757. PubMed ID: 32453790 [TBL] [Abstract][Full Text] [Related]
15. NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery. Jørgensen KW; Rasmussen M; Buus S; Nielsen M Immunology; 2014 Jan; 141(1):18-26. PubMed ID: 23927693 [TBL] [Abstract][Full Text] [Related]
16. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions. Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220 [TBL] [Abstract][Full Text] [Related]
17. Peptide binding motifs for MHC class I and II molecules. Biddison WE; Martin R Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1I. PubMed ID: 18432645 [TBL] [Abstract][Full Text] [Related]
18. NetCTLpan: pan-specific MHC class I pathway epitope predictions. Stranzl T; Larsen MV; Lundegaard C; Nielsen M Immunogenetics; 2010 Jun; 62(6):357-68. PubMed ID: 20379710 [TBL] [Abstract][Full Text] [Related]
19. A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules. Pandya M; Rasmussen M; Hansen A; Nielsen M; Buus S; Golde W; Barlow J Immunogenetics; 2015 Nov; 67(11-12):691-703. PubMed ID: 26496773 [TBL] [Abstract][Full Text] [Related]
20. Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery. Hansen AM; Rasmussen M; Svitek N; Harndahl M; Golde WT; Barlow J; Nene V; Buus S; Nielsen M Immunogenetics; 2014 Dec; 66(12):705-18. PubMed ID: 25186069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]